• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

希腊结核性胸腔积液患者的耐药模式。

Patterns of drug resistance among patients with tuberculous pleural effusion in Greece.

作者信息

Anastasakos V, Skouras V, Moschos C, Tsikrika S, Karabela S, Marinou I, Vogiatzakis E, Konstantinou K, Papavasiliou A, Kalomenidis I

机构信息

Department of Critical Care & Pulmonary Medicine, Medical School of Athens University, Evangelismos General Hospital, Athens.

Department of Pulmonary Medicine, 401 General Army Hospital of Greece, Athens.

出版信息

Int J Tuberc Lung Dis. 2017 Mar 1;21(3):309-313. doi: 10.5588/ijtld.16.0155.

DOI:10.5588/ijtld.16.0155
PMID:28225341
Abstract

SETTING

Data on the relationship between pleural tuberculosis (TB) and anti-tuberculosis drug resistance are scarce.

OBJECTIVE

To determine the patterns of drug resistance among pleural Mycobacterium tuberculosis isolates in Greece and the incidence of tuberculous pleural effusion (TPE) among patients with multidrug-resistant (MDR) or extensively drug-resistant (XDR) pulmonary TB.

DESIGN

Drug susceptibility testing (DST) results recorded in the database of the National Reference Centre for Tuberculosis in Athens, Greece, over a 9-year period (2003-2011) were reviewed. Chest X-rays from hospitalised patients with pulmonary MDR/XDR-TB during the same period were also reviewed for the presence of TPE.

RESULTS

Resistance to at least one first-line drug was observed in 11% of the cases (MDR-TB 3%, XDR-TB 1%), while 29% of the patients with pulmonary MDR/XDR-TB presented with TPE during the course of their disease, the majority ipsilateral to the lung lesions, which responded to guided anti-tuberculosis treatment.

CONCLUSION

The prevalence of drug resistance among pleural M. tuberculosis isolates in Greece highlights the importance of DST prior to treatment selection in TPE patients. In our study population, TPE that developed in one third of the patients with pulmonary MDR/XDR-TB usually resolved with DST-guided anti-tuberculosis treatment.

摘要

背景

关于胸膜结核(TB)与抗结核药物耐药性之间关系的数据很少。

目的

确定希腊胸膜结核分枝杆菌分离株的耐药模式以及耐多药(MDR)或广泛耐药(XDR)肺结核患者中结核性胸腔积液(TPE)的发生率。

设计

回顾了希腊雅典国家结核病参考中心数据库中记录的9年期间(2003 - 2011年)的药物敏感性试验(DST)结果。还回顾了同期住院的MDR/XDR肺结核患者的胸部X光片,以检查是否存在TPE。

结果

11%的病例观察到对至少一种一线药物耐药(MDR-TB为3%,XDR-TB为1%),而29%的MDR/XDR肺结核患者在病程中出现TPE,大多数与肺部病变同侧,经针对性抗结核治疗后有反应。

结论

希腊胸膜结核分枝杆菌分离株的耐药率表明在TPE患者选择治疗前进行DST的重要性。在我们的研究人群中,三分之一的MDR/XDR肺结核患者出现的TPE通常通过DST指导的抗结核治疗得以缓解。

相似文献

1
Patterns of drug resistance among patients with tuberculous pleural effusion in Greece.希腊结核性胸腔积液患者的耐药模式。
Int J Tuberc Lung Dis. 2017 Mar 1;21(3):309-313. doi: 10.5588/ijtld.16.0155.
2
Drug resistance in patients with tuberculous pleural effusions.结核性胸腔积液患者的耐药性。
Curr Opin Pulm Med. 2018 Jul;24(4):374-379. doi: 10.1097/MCP.0000000000000483.
3
Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.巴基斯坦肺结核复治病例一线和二线耐药模式。
Int J Tuberc Lung Dis. 2017 Mar 1;21(3):303-308. doi: 10.5588/ijtld.16.0444.
4
Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.缅甸广泛耐药结核病:二线药物耐药相关的负担和突变。
Int J Tuberc Lung Dis. 2018 Jan 1;22(1):47-53. doi: 10.5588/ijtld.17.0321.
5
Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.耐多药结核病广泛耐药危险因素:病例对照研究。
Int J Tuberc Lung Dis. 2018 Jan 1;22(1):54-59. doi: 10.5588/ijtld.17.0387.
6
Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011.2011年越南耐多药结核病患者对二线抗结核药物的耐药率
Western Pac Surveill Response J. 2016 Jun 8;7(2):35-40. doi: 10.5365/WPSAR.2016.7.2.002. eCollection 2016 Apr-Jun.
7
Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.肺切除术联合基于异烟肼和利福平的药物治疗用于耐多药和广泛耐药结核病患者。
Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.
8
Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China: A five-year review.中国国家结核病临床中心广泛耐药结核病及附加耐药的流行状况和治疗结局:一项为期五年的回顾性研究。
J Infect. 2017 Nov;75(5):433-440. doi: 10.1016/j.jinf.2017.08.005. Epub 2017 Aug 11.
9
Extensively drug-resistant tuberculosis in california, 1993-2006.1993 - 2006年加利福尼亚州的广泛耐药结核病
Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.
10
Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India.印度北部一家三级护理中心的肺外结核病病例的耐药模式。
Int J Tuberc Lung Dis. 2017 Oct 1;21(10):1112-1117. doi: 10.5588/ijtld.16.0939.

引用本文的文献

1
Drug-Resistant (DR) Tubercular Pleural Effusion: A Rare Case.耐药性结核性胸腔积液:1例罕见病例
Cureus. 2022 Nov 7;14(11):e31185. doi: 10.7759/cureus.31185. eCollection 2022 Nov.
2
A Rare Case of Multidrug-Resistant Tuberculosis Affecting the Pleura.1例累及胸膜的耐多药结核病罕见病例
Cureus. 2022 Jan 28;14(1):e21690. doi: 10.7759/cureus.21690. eCollection 2022 Jan.